Research Article
Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound
Table 2
Size of the lesions (in mm) and their perfusion parameters.
| | | | Size (SD) | Min/max size | Peak (SD) | TTP (SD) | RBV (SD) | RBF (SD) |
| | Adenoma | 1 | 35 | NA | 52.6 | 20.4 | 4818.5 | 70.1 | | CCC | 3 | 65 (22) | 50/90 | 9.4 (5.0) | 87.0 (48.8) | 920.1 (290.5) | 9.9 (4.9) | | FNH | 2 | 33 (3) | 31/35 | 51.8 (0.1) | 29.3 (11.4) | 4660.3 (439.0) | 67.3 (2.2) | | Haemangioma | 4 | 27 (12) | 14/41 | 45.7 (9.3) | 30.3 (6.8) | 4426.8 (2050.3) | 58.8 (16.2) | | HCC | 5 | 66 (26) | 46/111 | 21.5 (12.5) | 46.5 (36.5) | 1258.0 (576.6) | 25.6 (15.4) | | Liposarcoma | 1 | 45 | NA | 3.4 | 122.1 | 579.5 | 3.3 | | Metastasis | 4 | 50 (25) | 28/85 | 26.5 (14.9) | 47.7 (36.8) | 2036.9 (1327.8) | 33.2 (19.6) |
|
|
Benign lesions: focal nodular hyperplasia (FNH), adenoma, and haemangioma. Malignant lesions: hepatocellular carcinoma (HCC), cholangiocellular carcinoma (CCC), metastases, and liposarcoma. SD: standard deviation.
|
